Načítá se...
Recent Findings in the Posttranslational Modifications of PD-L1
Immune checkpoint therapy, such as the reactivation of T-cell activity by targeting programmed cell death 1 (PD-1) and its ligand PD-L1 (also called B7-H1 and CD274) has been found pivotal in changing the historically dim prognoses of malignant tumors by causing durable objective responses. However,...
Uloženo v:
| Vydáno v: | J Oncol |
|---|---|
| Hlavní autoři: | , , , , , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
Hindawi
2020
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7199566/ https://ncbi.nlm.nih.gov/pubmed/32377193 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1155/2020/5497015 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|